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ABSTRACT
Susceptibility of Borrelia burgdorferi Morphological Forms to Chemical Antimicrobials
Ann-Aubrey Kaiwilani Reid
Department of Microbiology and Molecular Biology
Master of Science
Borrelia burgdorferi is the etiological agent of Lyme disease. Not much is known about
the susceptibility of this organism to chemical disinfection. Current antimicrobial susceptibility
test methods, such as those published by the American Society for Testing and Materials
(ASTM), usually require assessment of the number of colony forming units (cfu) of growing
organisms on plates following exposure to an agent. For fast-growing organisms, plates are
ready for counting 1-2 days post plating, while several weeks may be needed for slower growing
organisms. Spirochetes, like B. burgdorferi are difficult to grow on solid media and typically
require long incubation periods, sometimes up to several weeks, to generate visible colonies.
These issues make B. burgdorferi cfu assessment by plate counting difficult and unreliable.
Furthermore, Borrelia have a demonstrated capacity for pleomorphic forms, and can exist in
spirochete, round body, or biofilm forms, depending on culture conditions. Plate counts, by
nature, do not allow for assessment of morphological form changes. Additionally, the
susceptibility of B. burgdorferi pleomorphic forms to chemical disinfectants has not been tested.
In this study, we used the SYBR GREEN I/Propidium Iodide (SG I/PI) viability assay to rapidly
estimate the percent kill of B. burgdorferi pleomorphic forms to chemical disinfection.
Planktonic spirochete populations in 30-second treated samples showed viability percent values
of: >95% for Hanks balanced salt solution (HBSS), ~60% for distilled deionized H2O (dd H2O),
<5% for ACS 200, and 1% for 1% glutaraldehyde (GTA). Solutions containing 70% ethanol
(ETH) and 1% hypochlorite (HC) showed no viable spirochetes following treatment. The percent
of live round body cells following different treatments were: >99% for HBSS and <25% for dd
H2O. ACS 200, 1% GTA, and 70% ETH treatments resulted in <1% live round body forms,
whereas HC showed no live round cell forms. The susceptibility of B. burgdorferi biofilms to
various treatments was also assayed using a SG I/PI viability stain after 30-minute contact times.
The percent of viable organisms (green) in the treated biofilms was estimated by microscopic
observations. HBSS controls showed >98% of bacteria in the biofilm were alive, while treated
biofilms showed the following percent viabilities: ACS 200 - ~2%, 1% HC - <1%, 5% HC <1%, 1% GTA - ~10%, 70% ETH - ~ 2%, and dd H2O ~40%. These techniques merged
standardized assessment of antimicrobial activity in liquid culture using an ASTM-type kill-time
procedure with viability techniques used in antibiotic susceptibility testing to rapidly evaluate the
percent kill of B. burgdorferi pleomorphic forms in vitro following disinfectant exposure. These
results showed that B. burgdorferi biofilm forms are orders of magnitude more resistant to
chemical disinfection than other morphological forms of this organism.
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INTRODUCTION
1.1 Disinfection of Lyme Spirochete
Literature suggests that Borrelia burgdorferi sensu lato can be inactivated with heat, UV
light, 1% HC and 70% ETH [37]. Heat-killed Borrelia or isopropyl/ethyl-alcohol killed Borrelia
are often used in producing “dead” spirochetes for various assays [73-74] [89]. However, to our
knowledge, no studies involving kill-time disinfectant assays have been recorded in the
literature. Additionally, a rapid contact disinfection assay has not been established to assess the
susceptibility of the major morphological forms of Borrelia; single spirochetes, round body, and
biofilm-like colonies. The purpose of these studies is to establish an assay that can be used to
determine the antimicrobial susceptibility of the different morphological forms of B. burgdorferi
to chemical disinfection.
1.2 Difficulty in Classical Disinfection testing with B. burgdorferi
Borrelia are slow growing with a doubling time between 12 and 24 hours and require
special growth media supplements [39-42]. This makes typical contact disinfection analyses
difficult, as standardized testing usually requires plate counts of colony forming units. The plates
used in standard Borrelia growth are bi-layered with a thicker bottom layer and a less dense top
agar overlay. This method of plating is difficult to replicate, and exceedingly labor intensive
when used in a standard disinfection assay. It has been reported that once prepared under these
optimal conditions, Borrelia colonies can be seen with the unaided eye 3-4 weeks post
inoculation [43]. Colonies that do form are also quite small and can be difficult to locate [44].
Barbour described Borrelia burgdorferi growth on plates as a “lawn”, prior to the generation of
media that allowed for individual isolated colonies of the Lyme spirochete [40]. Moreover,
potentially not all viable Borrelia on plates will form colonies, as Borrelia spirochetes are prone
to forming aggregates, and can also change to round body forms, which may require further
1

extended incubation periods prior to reverting into spirochetes that can then form colonies. These
issues complicate disinfection protocols and require several weeks of incubation time prior to
data collection. In addition, plate counts limit the ability to assess quantitative and qualitative
morphological changes of Borrelia spirochetes to round body forms.
1.3 Purpose of B. burgdorferi Disinfection Testing
To better understand the effect of chemical antimicrobials on B. burgdorferi, the standard
chemical antimicrobial assay was modified for rapid assessment of susceptibility and
morphological change from spirochete to round body. A better understanding of the effects of
chemical antimicrobials on the major morphological forms of B. burgdorferi is critical to the
proper handling and disinfection of this microbe.
In these studies, we developed an evaluation method for the analysis of chemical
disinfectant efficacy against the different morphological forms of Borrelia burgdorferi, using
viability dye assessment in combination with standardized ASTM-type kill-time suspension
testing. Novel growth and viability assessment techniques formulated in the laboratory of Eva
Sapi, that were originally designed for the analysis of antibiotic efficacy against three different
forms of Borrelia burgdorferi (spirochetes, round bodies, and biofilm-like colonies) [2] [9], were
utilized in combination with standardized kill-time suspension techniques, to test the
effectiveness of chemical disinfectants that could be used to kill Borrelia burgdorferi in a lab or
clinical setting. Our goal was to establish an in vitro system to analyze contact kill times for
Borrelia burgdorferi morphological forms, using chemical antimicrobials, in order to better
understand the susceptibility of the pleomorphic variations of the Lyme spirochete.
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BACKGROUND
2.1 Discovery of Lyme Disease
Lyme disease is a tick-borne illness caused by the Borrelia burgdorferi spirochete. Over
the last decade, Lyme disease has become more prominent and grown into a major public health
problem. The disease has been noted in the United States, Central Europe, and parts of Asia.
Lyme disease shows equal prevalence in men and women, and can be found among all age
groups, including children [13-14]. First described and discovered in Old Lyme, Connecticut in
1975, adolescent arthritis became a major noted concern among residents, and this ultimately led
to the discovery of Borrelia burgdorferi as the causative agent of Lyme disease [10-11]. Dr.
Alan Steere initially described Lyme disease as a clinical manifestation of an infectious illness
and suggested the transmission of the agent through arthropod vectors. Thereafter, Dr. Willy
Burgdorfer and coworkers isolated spirochetes from the midguts of ticks. They found that when
these spirochetes were injected into rabbits, it resulted in the production of a rash similar to the
erythema migrans seen in some Lyme patients [38]. Subsequently, the bacterial species was
named Borrelia burgdorferi.
2.2 Introduction to Borrelia Burgdorferi
In Europe and Asia, Borrelia Burgdorferi senu strictu (s.s), B. garinii, and B. afzelii,
which are collectively known as B. burgdorferi sensu lato (s.l), are the three major genotypes of
Borrelia responsible for most human cases, although additional genotypes are being identified.
Lyme disease in the US is generally thought to be caused by Borrelia burgdorferi alone [65].
The United States Center for Disease Control and Prevention (CDC) estimates about 300,000
[79] new infections annually in the United States alone [15] [67-68]. Increased exposure to tick
habitats or Ixodes tick hosts, increases the risk for contracting Lyme disease. Current research
has been focused mainly on antibiotic efficacy against Borrelia, the different pleomorphic forms
3

of the organism, protein regulation necessary for survival in multiple hosts types, and persistent
infections [9]. However, very little research has been done on this organism’s susceptibility to
disinfection.
2.3 Transmission and Life Cycle
Lyme Disease is known to be transmitted by tick vectors, namely of the genus Ixodes in
the Unites States. These tick vectors find hosts among a wide range of vertebrate animals
including small and large mammals, birds, and lizards [38] [78]. Though less studied and less
understood, clinical signs attributed to Lyme disease have been reported in dogs, cattle and
horses [16] [28-29]. Worldwide geographic distribution of Lyme disease in Humans tracks with
several species of ticks that serve as vectors, and varying genospecies of Borrelia. In the western
Unites States, I. pacificus (the western black-legged tick) and in the northeastern and midwestern
U.S., I. scapularis (the black-legged tick), are the primary tick species that cause human disease.
In Europe, I. rininus (the European sheep tick) is the main agent of Lyme dissemination, and in
Asia, I. persulactus (the taiga tick) is the main vector [80-81]. However, newly discovered tick
vectors and Borrelia spp. variants are becoming apparent [82]. Larval, nymphs, and adult ticks
acquire spirochetes when feeding on infected animals. Frequently, larva feed on small animals
such as infected rodents, while nymphs and molted adult ticks often feed on larger animals [38].
Once they become carriers, ticks host the spirochetes often for life. Infected ticks feed on a large
range of animals, which then become new reservoirs to continue the cycle. When an infected tick
feeds upon a human, the spirochete can permeate the skin and begin dissemination through the
body. Nymphs are small and often difficult to detect, which make them more likely to attach
long enough to transmit the spirochete before being removed.
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Ticks and mammalian hosts are exceedingly different environments for bacterial growth.
Tick ambient temperature will fluctuate, depending on its surroundings and host attachment,
while mammalian hosts regulate their body temperature between 37o-39oC. Additionally,
mammalian host blood and tissue pH are more neutral, compared to the more basic environment
found in the tick midgut. Borrelia adapt to these environmental changes with variable gene
expression, which alters protein components and stimulates regulatory migration based on
external cues during a tick blood meal [83].
Though controversial, there is some evidence to support the idea that Borrelia can be
transmitted by sexual contact. Borrelia spirochetes have been cultured from and identified in
human vaginal and seminal secretions [79]. Serological and genetic identification of Borrelia in
genital secretions suggests at least the possibility that sexual transmission of the spirochete and
initiation of disease may occur.
2.4 Symptomology of Lyme Borreliosis
Lyme disease is a multisystem disorder that results in flu-like symptoms, which if left
untreated, can develop into more severe complications [84]. Lyme patients often exhibit
nonspecific symptoms such as headache, myalgia, arthralgia, shaking chills, and abdominal
complaints [76]. More severe symptoms might include extreme fatigue, musculoskeletal
symptoms, neurological problems, and/or cardiac abnormalities, which may present weeks to
months after initial infection [10-11]. The most easily recognizable and diagnosable presentation
sign of Lyme disease is a bulls-eye skin rash called erythema migrans, which usually appears at
the bite site [14]. The rash exhibits, as the name suggests, a rash that looks like a bull’s eye target
with rash rings centered around a focal point. This focal point is thought to be the where the tick
initiated a blood meal, with subsequent dissemination of Lyme spirochetes throughout the skin.
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Though the well-known bull’s eye rash is easily identified and recognized, only a fraction of
Lyme patients exhibit this presentation. In mouse models, Borrelia burgdorferi has also been
implicated in bone building inhibition, resulting in trabecular bone loss and demineralization
[86].
2.5 Treatment of Lyme Borreliosis
The increasing prevalence of Lyme disease has been attributed to poor preventative
measures, suboptimal treatments, and lack of information regarding Borrelia infection.
Antibiotics administered as a frontline treatment for Lyme disease include doxycycline,
minocycline, amoxicillin, cefuroxime, and ceftriaxone [9]. Although antibiotic treatment for 2-4
weeks is typically successful for early stages of Lyme disease, studies have shown that not all
patients are cleared of infection. These patients then continue to have Lyme disease symptoms
that persist. Morphological forms of Borrelia burgdorferi may contribute to treatment failures
[87-88].
2.6 Morphological Forms of Borrelia burgdorferi
Borrelia burgdorferi is known to be capable of existing in several alternate morphologies
when exposed to harsh or changing environmental conditions [1-6]. In addition to its typical
spirochete form, the Lyme bacteria can transform from this corkscrew shape into round body cystlike forms. Unfavorable condition such as high pH, adverse temperatures, nutrient starvation, and
altered osmotic pressure can induce formation of the round body form from spirochetes [7-8].
These round bodies also have the capacity to revert back into vegetative motile spirochetes in vitro
[1] and in vivo [4]. In addition to these single cell forms, Borrelia can aggregate into functional
biofilms which can protect internal resident spirochetes from unfavorable external conditions [2]
[9]. These alternate morphologies may be a critical part of Borrelia burgdorferi’s ability to survive
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hostile environments. It has been shown that these morphological forms (single spirochetes, round
body forms, and biofilm-like-colonies), can protect the bacteria in different instances, such as
when they are exposed to antibiotics in vitro [9].
2.6.1 Borrelia burgdorferi Spirochete
Borrelia burgdorferi is well known as the Lyme Disease spirochete. Characterized as a
flat-wave spirochete, it is known that the flagella component of Borrelia is critical in
determining its shape [65-66]. The cell envelope of Borrelia burgdorferi includes a protoplasmic
cylinder which is covered by two lipid membranes [55]. The periplasmic space contains the
peptidoglycan layer and flagellar filaments, located between the outer and inner membrane [57].
Borrelia burgdorferi have multiple periplasmic flagella bundled together in structures called
axial filaments that attach at each end of cell and overlap in the middle. This constrains the
bacterium into an elongated spirochete shape. The two flagellar bundles located at each end of
the cell provide motility by propelling the spirochete in a corkscrew like motion, which allows
for easier movement through viscous media [60-63]. The intersection of the two axial filaments
in the middle of the cell is also the site of a flexing motion, often seen while spirochetes are
suspended in free motion [64]. Characteristically, Borrelia are approximately 0.2 µm in diameter
and 10-30 µm in length, though length can vary significantly depending on growth conditions
[66]. Unlike classic gram-negative bacteria, Borrelia burgdorferi lack lipopolysaccharides
(LPS), which are normal outer membrane components, and have immunoreactive glycolipids in
their place [58-59].
2.6.2 Borrelia burgdorferi Round Body
Current literature has reported that Borrelia spirochetes can transform into round body
forms, which are also called L-forms, cystic forms, and cell wall deficient forms [30-31]. These

7

round body forms have been observed as a small fraction of a typical Borrelia culture and can be
induced with antimicrobials and human spinal fluid when cultured in vitro [1]. Induction of
round body Borrelia can be accomplished by stressing the cells through osmotic stress,
starvation, antibiotic treatment and pH extremes outside of the typical Borrelia growth range [56]. Round body forms have been reported to be a functional way of potentially protecting the
spirochete for a time until more favorable conditions arise, at which time spirochetes can
reemerge and continue metabolic activity. As the spirochete changes to a round form, the outer
membrane make up also changes in a way to protect the spirochete from unfriendly
environments, such as antibiotic treatment [33-35]. Rapid induction of the round body form can
be accomplished by subjecting spirochetes to distilled deionized (dd) H2O. On contact with this
hypotonic environment, spirochetes will shift to round body forms, with longer exposures
resulting in increased round body counts, and increased spirochete reversion time when they are
returned to optimal growth conditions [34]. To date, round body susceptibility to antibiotics have
been shown in vitro [2], but no similar assessments of round bodies to chemical antimicrobials
have been tested.
2.6.3 Borrelia burgdorferi Biofilm
Among the Spirochaetales, Leptospira spp, and Treponema denticola have been
reportedto contribute to biofilms [20-22]. Similarly, biofilm formation has been reported in
Borrelia burgdorferi, and has been associated with protection of the organism from antibiotic
treatment in vitro [9] [18] [25-28]. These biofilms are a complex conglomeration of Borrelia
burgdorferi spirochetes that serve to protect associated spirochetes from hostile or unfavorable
environments. Borrelia have been shown to display several known hallmarks of biofilms in vitro
[9] [18]. For instance, structural rearrangements of the aggregates, variable stages of
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development on varying substrate matrices, and secretion of a protective extracellular polymer
substance (EPS) matrix have been opbserved. Sapi et al. showed multi-level rearrangements take
place at different stages of the aggregate biofilm colony development. Atomic force microscopy,
which allows live imaging of cells without fixation, showed the arranging formation of Borrelia
spirochetes in a biofilm to be progressive over time [2]. The Sapi lab also showed that individual
spirochetes were observed on agarose layers, but often were observed in pairs, which, within a
few days would begin to acquire more spirochetes and generate complex structure formations,
until large aggregates and biofilm were generated. These aggregates then produced a complex
and continuously changing structure, thought to reintroduce fresh resources and exchange waste
to each segment for the biofilm. This same group also showed that these developing biofilms
form on several abiotic and biotic substrates [2]. In addition, Borrelia burgdorferi spirochetes are
also capable of forming floating aggregate biofilms in liquid media. Analysis of the extracellular
substances of these aggregates showed them to be exopolysaccharides containing both sulfonated
and non-sulfanated/carboxylated substrates, which are common in various bacterial biofilms.
Literature also has shown that the exopolysaccharides are predominately composed of an
alginate in combination with calcium and extracellular DNA. These components present in
Borrelia burgdorferi biofilms are known components of biofilms produced by other medically
relevant bacteria [2][9] [19] [23]. The rigidity of the biofilm structure can be felt by rubbing the
coverslip over the wet mount of a biofilm sample and an audible crunching sound is produced
(A. Reid, unpublished observations). Borrelia biofilm formation has been shown to protect the
organism from antibiotic penetration and allow organism persistence through treatment in vitro
[9].
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2.7 Growth Conditions and Division
Originally, Borrelia was cultured in specialized liquid Barbour-Stonner-Kelly (BSK)
medium. Currently, there are variations of BSK medium, such as BSK-H, BSK-S, BSK-II and
others, which have been altered with variable serum concentrations needed to optimally culture
Borrelia in vitro [40-41] [44]. BSK medium is highly enriched with bovine serum albumin and
heat-inactivated rabbit serum to promote growth. Cultures are typically incubated in a
microaerophilic environment of 5% CO2 at the optimal temperature of 33oC [9] [53]. Borrelia
burgdorferi is a human pathogen, so even though the optimal growth temperature is about 33oC,
it can manage at 37oC. Generally, spirochetes grow slowly and Borrelia burgdorferi doubles
about every 12 hours. In a fashion unique to the genus Borrelia, these spirochetes elongate from
specific zones of peptidoglycan accumulation which are regulated spatially and temporally. A
new cell is born with a central region that produces larger quantities of peptidoglycan relative to
the rest of the cell, while the poles of the spirochete remain inert. As the cell cycle progresses,
the spirochetes produce additional regions of increased peptidoglycan production at about the ¼
and ¾ regions on the spirochete. These areas elongate the cell in both directions, followed by
DNA segregation, and septate formation. As the mid-cell region completes septation, the region
becomes an inert region relatively lacking peptidoglycan on either end of the new daughter cells.
The daughter cells mid-cell origins are then established where the mother cells ¼ and ¾
peptidoglycan dense regions formed. [75-76]
2.8 Live/Dead Differentiation of Lyme Spirochetes
To differentiate live and dead Borrelia forms: spirochetes, round body, and biofilm,
darkfield microscopy was used to visualize the planktonic or aggregated cells. Darkfield
microscopy allows for easy viewing of an otherwise thin and difficult to view bacterium. As the
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organisms appear as bright objects surrounded by a dark background, the contrast allows for
simple spirochete identification [69]. Often, live spirochetes are characterized by active motility
while impaired or no motility can indicate cell death [33] [69-72]. These motile cells can be
counted to estimate the number of viable spirochetes in a population [62-63]. In addition to
darkfield microscopy, fluorescent viability dyes can be used to stain the organisms and achieve
percent live/dead measurements [2] [9]. These dyes offer a more accurate measure of a cell’s
viability status through selective membrane permeability of the dyes; where live cells are
impermeable to selective dyes while dead cells with damaged membranes allow such dyes to
pass into the cell. [53] [73].
MATERIALS AND METHODS
3.1 Strain, Media and Culture
B. burgdorferi B31 strain was obtained from the American Type Tissue Collection
(ATCC 35210). B. burgdorferi was cultured in BSK-H medium containing 6% rabbit serum.
BSK base was prepared in 250 ml batches. Each batch was made by mixing part A components
in 200ml of dd H2O using magnetic stirring for 1 hour at room temperature, after which part B
components were added and the medium was further mixed for another hour. Dd H2O was used
to bring the total volume to 250 ml. It was then mixed an additional 30 minutes prior to filtration.
All culture media were filter-sterilized through a 0.22 µm filter. Cultures were incubated in
sterile 15 ml closed conical tubes at 33⁰C and 5% CO2, without antibiotics, and grown to midlate log phase. Cultures were kept at low passages (3-10 passages). Homogenous cultures of
spirochetes without biofilm formation were obtained by maintaining the cultures in a shaking
incubator with tight lids at 33⁰C and 250 rpm [9].
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The methods used to prepare B. burgdorferi biofilm cultures using 24 well tissue culture
plates, were as previously described [9]. Briefly, for the generation of Borrelia burgdorferi
biofilms, 100 µl of active culture (2 X 106 spirochetes) were transferred into 24 well plates
containing one ml fresh BSK-H media supplemented with 6% rabbit serum and incubated at
33⁰C and 5% CO2 for 10 days without shaking. After 10 days of incubation, biofilm-like
colonies were examined and confirmed by darkfield microscopy. Contents of the wells were
transferred to 1.5 ml centrifuge tubes, centrifuged and washed with one ml of Hank’s Balanced
Salt Solution (HBSS), then exposed to chemical antimicrobials prior to crystal violet assay or SG
I/PI viability assay.
3.2 Microscopes
Specimens of Borrelia burgdorferi cultures or cells were examined using a Zeiss Imager
A1 microscope equipped with a darkfield condenser and a darkfield oil immersion 63X objective
lens. A separate Zeiss A1 imager equipped with fluorescence capabilities was used for
fluorescent analysis. Both microscopes were equipped with Zeiss Axiocam 503 color cameras.
3.3 Darkfield Microscopy
Initially, darkfield microscopy was used to assess cell viability by observing motility
following disinfectant exposure. Samples were analyzed through cell counts in a Petroff-Hauser
counting chamber-3902, under darkfield microscopy post contact with disinfectants. Borrelia
burgdorferi were grown to log phase, washed in Hanks Balanced Salt solution (HBSS), and
concentrated to 5 X 108 spirochetes/ml. Spirochetes were placed in 1.5 ml centrifuge tubes (~5 X
108 spirochetes/ml) and centrifuged at 10,000 xg for 10 minutes, then washed with HBSS. Cell
pellets were re-suspended in one ml of disinfectant and homogenized gently by pipetting. After
specified contact times (30 seconds, 1 minute, 3 minute), 0.1 ml of cell suspension was placed in
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0.9 ml of neutralizer (~ 5 X 107 spirochetes/ml). After mixing, the suspension was centrifuged
and washed in HBSS. Cells were viewed and counted at 200X magnification in a Petroff-Hauser
counting chamber-3902 under darkfield microscopy. Motile and non-motile spirochetes or round
body forms were counted. Assays were performed in triplicate.
3.3.1 Step-wise Borrelia Motility Darkfield Microscopy Assay:
1. Transfer one ml of 1 X 109 spirochetes into 1.5 ml centrifuge tubes
2. Centrifuge at 10,000 xg for 5 minutes
3. Discard the supernatant
4. Wash with one ml of HBSS
5. Centrifuge at 10,000 xg for 5 minutes
6. Discard the supernatant
7. Add one ml of disinfectant to the bacterial pellet
8. Re-suspend the cells with gentle and swift pipette motions in disinfectant
9. At contact time 30 seconds, 1 minute, and 3 minutes transfer 100 ul of treated cells into
900ul of neutralizer in a separate 1.5 ml centrifuge tube
10. Vortex
11. Centrifuge at 10,000 xg for 5 minutes
12. Discard the supernatant
13. Wash with one ml of HBSS
14. Centrifuge at 10,000 xg for 5 minutes
15. Discard the supernatant
16. Gently re-suspend the pellet in one ml HBSS
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17. Count with Petroff-hauser counting chamber-3902 under darkfield at 200X
magnification
18. Count cells for total concentration, round body presence, and motility
Statistical analysis run with Two-Way ANOVA with Dunnett’s multiple comparison test; ****
where p<0.0001 and * where p<0.02 using Graph Prism software.
3.4 Heat Kill Protocol
An active culture of Borrelia burgdorferi was pelleted by centrifugation at 3,000 xg for
15 minutes at room temperature, and the pellet was washed once in HBSS. The pellet was resuspended in HBSS (preheated to 55⁰C) and the suspension was maintained in a 55⁰C water bath
for 20 minutes. Spirochete death was confirmed by loss of motility under darkfield and SG I/PI
viability staining. Spirochete density was adjusted to 109 spirochetes/ml stock solution as
counted in a Petroff-Hauser counting chamber-3902 under darkfield microscopy.
3.5 SG I/PI 96-well Plate Viability Assay and Fluorescent Microscopy
For assaying the live/dead percentages, cells in 96-well plates were stained with SG I and
PI nucleic acid stains. SG I (10,000 X stock, Invitrogen) (10 µl) and 30 µl of PI (20 mM, Sigma)
were added to 1.0 ml of sterile dd H2O and the tube was vortexed until completely mixed. The
staining mixture (10 µl) was added to each well containing 100 µl of cell suspension and the
contents were mixed thoroughly. The plates were incubated in the dark at room temperature for
15 minutes. The plates were assayed for fluorescence using a BioTek Synergy HT plate reader,
with the excitation wave length set at 485 nm, and the fluorescence intensities monitored at 535
nm (green emission) and 635 nm (red emission).
The prepared suspensions of B. burgdorferi for the generation of standard curves used
live and heat killed Borrelia burgdorferi in seven different proportions (100%, 87.5%, 75%,
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50%, 25%, 12.5%, 0% live cells). These were prepared in 96-well plates using the mixy-mix
method. The SG I/PI dye mix was added to each well and the Green/red fluorescence ratios were
measured at each of the proportions in multiple replicates, using the BioTek plate reader.
Regression equations were generated using the least-square fitting analysis of the ratios of green:
red (live: dead) Borrelia burgdorferi. The regression equation obtained was used to calculate the
percentage of live Borrelia burgdorferi cells in each well.
Borrelia burgdorferi spirochete homogenous cultures were grown to mid-late log phase,
washed twice in HBSS, and concentrated to 1 X 109 cells/ml. To generate mixy-mix proportions
for the standard curve, a 1 X 108 cells/ml dilution was prepared and split in half. Half of the
mixture was heat killed and the other half was kept in HBSS at room temperature to serve as live
cells. The heat-killed suspension was placed on ice and warmed to room temperature before
mixing with live cells when preparing the standard curve proportions.
Test samples were made by placing one ml (~1 X 109 cells/ml) of culture in 1.5 ml
centrifuge tubes. Samples were centrifuged for 10 minutes at 10,000 xg at room temperature.
Supernatant fluid was discarded, and pellets were washed with one ml HBSS and centrifuged
again to pellet the sample. Pellets were re-suspended in one ml of disinfectant. After specified
contact times (30seconds, 1 minute, 3 minutes), 100 µl was added to 900 µl neutralizer in a 1.5
ml centrifuge tube and vortexed (~1 X 108 cells/ml). The tube was centrifuged for 10 minutes at
10,000 xg at room temperature and the cells were washed once with HBSS. The pellet was resuspended in one ml HBSS and mixed gently. A 200 µl aliquot of the samples was transferred to
a 96-well plate (~2 X 107 spirochetes per well). Twenty µl of SG I/PI dye was added to each well
and the contents were mixed well. Plates were incubated in the dark for 15 minutes, then assayed
for fluorescence on a BioTek Synergy HT plate reader with the excitation wave length set at 485
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nm, and the fluorescence intensities at 535nm (green emission) and 635 nm (red emission).
Samples were also examined with a fluorescent microscope to confirm counts in comparison
with the darkfield counts and the percent live calculations from 96-well plate assays.
Additionally, fluorescent direct counts were used to estimate percent change of spirochete to
round body forms induced by exposure to the disinfectant. Microscopy was performed on a Zeiss
Axio A1 fluorescent imager. Images were taken at 400 X.
3.5.1 Step-wise Borrelia SG I/PI 96-well plate viability assay:
1. Transfer one ml of 1 X 109 spirochetes into 1.5 ml centrifuge tubes
2. Centrifuge at 10,000 xg for 5 minutes
3. Discard the supernatant
4. Wash with one ml of HBSS
5. Centrifuge at 10,000 xg for 5 minutes
6. Discard the supernatant
7. Add one ml of disinfectant to the bacterial pellet
8. Re-suspend the cells with gentle and swift pipette motions in disinfectant
9. At contact times of 30 seconds, 1 minute, and 3 minutes, transfer 100 ul of treated cells
into 900ul of neutralizer in a separate 1.5ml centrifuge tube
10. Vortex
11. Centrifuge at 10,000 xg for 5 minutes
12. Discard the supernatant
13. Wash with one ml of HBSS
14. Centrifuge at 10,000 xg for 5 minutes
15. Discard the supernatant
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16. Gently re-suspend the pellet in one ml HBSS
17. Transfer 200 ul of treated sample into 96-well plate
18. Add 20ul of SG I/PI dye stock mixture and mix into each well
19. Incubate plates in the dark for 15 minutes at room temperature
20. Assay for fluorescence with the excitation wave length set at 485nm, and the
fluorescence intensities at 535nm (green emission) and 635nm (red emission)
21. Use 20 ul of dyed sample to observe under fluorescent microscopy, count round body
to spirochete ratio in 5 fields of view
Statistical analysis run with One-Way ANOVA with Dunnett’s multiple comparison test; ****
where p< 0.0001 using Graph Prism software.
3.6 Compete-Kill Growth Assay
To determine if all viable cells were killed by antimicrobial agents with strong percent kill
values as assessed by the 96-well plate viability assay and visual observance of non-motile cells
via darkfield microscopy, a complete-kill test was implemented. Viable spirochetes were treated
with antimicrobial agents as previously described at 30 seconds, 1 minute, and 3 minute contact
times for homogenous spirochete cultures and a 30 minute contact time for biofilm cultures.
After exposure to listed disinfectants, treated cells were washed and replaced with fresh BSK-H
media to assess for growth (G), or no growth (NG) observing spirochete motility under darkfield
microscopy. Spirochete motility was assessed at 3 weeks post inoculation.
3.6.1 Step-wise Borrelia Compete-Kill Growth Assay:
1. Follow 3.5.1 “Step-wise Borrelia SG I/PI 96-well plate viability assay” to step sixteen
2. Centrifuge at 10,000 xg for 5 minutes
3. Transfer 100 ul of treated cells into 900 μl of BSK-H media in 24 well plates
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4. Wrap edges in parafilm to prevent drying of plates
5. Incubate at 33⁰C and 5% CO2 for 3 weeks
6. Assay Growth (G) or no growth (NG) by darkfield microscopy at 630X magnification
3.7 Quantitative Crystal Violet Biofilm Assay
To quantify Borrelia burgdorferi biofilm-like colonies after treatment with various
chemical antimicrobials, 24-well plate were inoculated with 100 µl containing ~2 X 106
spirochetes into plates containing one ml fresh BSK-H media supplemented with 6% rabbit
serum. The plates were incubated at 33⁰C and 5% CO2 for 10 days without shaking. Contents of
the wells were transferred to 1.5 ml centrifuge tubes, washed, and exposed to chemical
antimicrobials for specified contact times and neutralized, as described above. Control wells
were treated with HBSS alone and run in triplicate.
This assay was used to determine the destruction of biofilm mass after a specified contact
time of 30 minutes, a significant increase from the 30 second contact times used on planktonic
cells, by the following tested chemical antimicrobials: 70% ETH, 1% GTA, 1% HC, 5% HC, dd
H2O, and ACS 200.
After 10 days incubation to generate a biofilm, the contents of the well were transferred
into a 1.5 ml centrifuge tube and centrifuged at 10,000 xg for 5 minutes. After discarding the
supernatant fluid, 0.5 ml of HBSS was added to all wells. Cell were re-suspended, washed once
with HBSS, and centrifuged again. Pellets were re-suspended in one ml of chemical disinfectant
for a 30-minute contact time, after which contents were placed into 9 ml of neutralizer, mixed,
centrifuged, and washed once with HBSS. Cells were re-suspended in 0.01% crystal violet for 10
minutes, centrifuged, and washed once with HBSS. Cells were centrifuged again and re-
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suspended in 200 µl cold 10% acetic acid for 15 minutes. Cells were centrifuged and supernatant
fluid was collected and placed into a 96-well plate, which was assayed for absorbance at 590 nm.
3.7.1 Step-wise Borrelia Biofilm Assay Using Crystal Violet:
1. Transfer the contents of each well into individually labelled 1.5 ml centrifuge tubes
2. Centrifuge at 10,000 xg for 5 minutes
3. Discard the supernatant
4. Add 500 μl of PBS to each 96-well plate well and add contents to the pellets in the
centrifuge tubes
5. Resuspend the cells by vortexing
6. Centrifuge at 10,000 xg for 5 minutes
7. Discard the supernatant
8. Add one ml HBSS
9. Resuspend the cells by vortexing
10. Discard supernatant
11. Add one ml chemical antimicrobial being tested
12. Resuspend by vortexing
13. Incubate at room temperature for 30 minutes
14. Take one ml of disinfectant/cell mixture from 1.5 ml centrifuge tube and transfer to 9
ml of neutralizer.
15. Vortex
16. Centrifuge at 10,000 xg for 5 minutes
17. Discard supernatant
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18. Wash with one ml HBSS and mix by vortexing, then transfer back to new individually
labelled 1.5 ml centrifuge tube
19. Add 100 µl of 0.01% crystal violet to the pellet.
20. Re-suspend the cells by vortexing
21. Incubate at room temperature for 10 minutes.
22. Centrifuge at 10,000 xg for 5 minutes
23. Discard the supernatant
24. Add 0.5 ml HBSS to the pellet to wash the biofilm.
25. Re-suspend the cells by vortexing
26. Centrifuge at 10,000 xg for 5 minutes.
27. Discard the supernatant.
28. Add 200 µl of 10% acetic acid to the pellet.
29. Re-suspend the cells by vortexing
30. Incubate at room temperature for 15 minutes
31. Centrifuge at 10,000 xg for 5 minutes
32. The clear solution is transferred to a 96-well plate and OD is measured at 590 nm
Statistical analysis run with One-Way ANOVA with Dunnett’s multiple comparison test; ****
where p<0.0001 and * where p<0.05 using Graph Prism software.
3.8 Qualitative Assessment of Borrelia burgdorferi Biofilm Using SG I/PI
To determine a qualitative value for the effect of chemical bactericidal agents on biofilmlike colonies of Borrelia burgdorferi, 2 X 106 cells from a homogenous culture of spirochetes
generated by shaking incubation at 250 rpm were inoculated into one ml of BSK-H in 24 well
plates and incubated at 33⁰C and 5% CO2 for 10 days. After 10 days incubation without shaking,
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biofilm-like colonies were observed in the wells. The contents of the well were removed and
placed into 1.5 ml centrifuge tubes and centrifuged at 10,000 xg for 5 minutes and washed once
in HBSS. One ml of disinfectant was added to the tube, which was then vortexed. After a 30 min
contact time, the contents were added to 9 ml of neutralizer in a 15 ml conical tube. After
mixing, the tube was centrifuged at 10,000 xg for 5 minutes and the pellet was re-suspended in
one ml HBSS and transferred back into a 1.5 ml centrifuge tube. Cells were then washed once
with HBSS and re-suspended in one ml HBSS. Ten µl SG I /PI dye mixture were added for each
100 ul of sample. The tube sat in the dark at room temperature for 15 minutes, and cells were
then viewed with a fluorescence microscope. Control wells were treated with HBSS alone and all
tests were repeated in triplicate. Images were taken at 400X magnification.
3.8.1 Step-wise SG I/PI Qualitative Assay Protocol for Borrelia Biofilm 30-minute
Contact Time:
1. Transfer the contents of the well into individually labelled 1.5ml centrifuge tubes
2. Centrifuge at 10,000 xg for 5 minutes
3. Discard the supernatant
4. Add 500 µl of HBSS to all wells. The contents of each well is transferred to centrifuge
tubes
5. Centrifuge at 10,000 xg for 5 minutes
6. Resuspend the cells in one ml HBSS by vortexing
7. Centrifuge at 10,000 xg for 5 minutes
8. Discard the supernatant
9. Add one ml HBSS
10. Resuspend the cells by vortexing
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11. Discard supernatant
12. Add one ml chemical antimicrobial being tested
13. Resuspend by vortexing
14. Let sit for contact time of 30 minutes
15. Take one ml of disinfectant-organism from 1.5ml centrifuge tube and transfer to 9 ml
neutralizer in 15 ml conical tube
16. Vortex
17. Centrifuge at 10,000 xg for 5 minutes
18. Discard supernatant
19. Wash with one ml HBSS and mix by vortexing
20. Transfer back to new labelled 1.5 ml centrifuge tube
21. Re-suspend in one ml HBSS by vortexing
22. Add 100 µl SG I/PI dye mixture
23. Vortex
24. Incubate at room temperature in the dark for 15 minutes.
25. View under fluorescent microscopy on a microscope slide
26. Count 5 fields of view
Statistical analysis was run with One-Way ANOVA with Dunnett’s multiple comparison test;
**** where p<0.0001 using Graph Prism software.
RESULTS AND DISCUSSION
4.1 Specified Modifications
The liquid suspension test methods utilized in this study were based on the ASTM
E2315-16 standard test method suitable for assessing bactericidal activity in liquid suspension
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[51]. Modifications were made to scale down the volumes to one-ml test sample sizes. In
addition, live/dead viability assessment of the samples via fluorescent viability dyes SG I and PI
replaced standard colony forming unit counts. All disinfection efficacy tests were conducted in
triplicate.
4.2 Motility Viability Assay
To evaluate in vitro chemical antimicrobial sensitivity of B. burgdorferi spirochete and
round body morphological forms, B. burgdorferi (B31-35210) was subjected to timed contact
with different disinfectants. Disinfectant sensitivity of spirochetes was evaluated using direct cell
counting and motility assessment using darkfield microscopy (Figure 1). Treatment with HBSS
showed that >99% of counted spirochetes were motile, while treatments with 70% ETH, 1%
GTA, ACS 200, and dd H2O showed <1% of organisms present were motile. In addition, 1% HC
showed no countable cells, presumably by inducing cell lysis.

FIGURE 1: B. burgdorferi Spirochete Darkfield Motility Counts. (A) B. burgdorferi spirochete viability by darkfield
microscopy motility estimation after disinfectant contact times of 1 minute, 3 minutes, 5 minutes, and 10 minutes. (B
Image of healthy spirochetes under dark-field microscopy. Image taken at 630X magnification. **** represents
strong visual evidence of significant deviation from the HBSS control without statistical analysis due to lack of
variance between means.

Using this method, we also calculated the change in round body presence when cells
were subjected to chemical antimicrobials (Figure 2). B. burgdorferi cultures naturally contain a
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small population of round body forms. However, the predominant form is the spirochete. Our
results showed that when in HBSS, the cultures contained ~5% round body forms. However,
ACS 200 and dd H2O increased round body presence to ~80% of the total countable population,
which is almost 13 times that of the control group. Interestingly, 1% GTA and 70% ETH showed
~ 5% round body forms (Figure 2A). No significant differences in round body induction were
observed between 30-sec and 10-min contacts (Figure 2A). Using this method, we found that 30
sec appeared to be a suitable contact time for the single cell disinfection assay. From this, we
concluded that though useful in viability detection in antibiotic assays, motility was not sensitive
enough to be useful in disinfection assays. Therefore, we used fluorescent live/dead viability
staining and direct counts for subsequent disinfection experiments.
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FIGURE 2: B. burgdorferi Round Body Darkfield Counts. (A) B. burgdorferi percent round body estimation by
darkfield microscopy after various contact times with different solutions. (B) B. burgdorferi exposed to HBSS viewed
with dark-field microscopy in a Petroff-Hausser bacterial counting chamber; image taken at 400X magnification.
(C) Darkfield image of B. burgdorferi round body forms induced by exposure to dd H2O; image taken at 630X
magnification. Statistical analysis run with Two-Way ANOVA with Dunnett’s multiple comparison test; **** where
p<0.0001 and * where p<0.02 using Graph Prism software.

4.3 SYBR GREEN I/PI Planktonic Cell Direct Counts
To examine in vitro viability of planktonic cells beyond motility, we used SG I/PI
viability stains to assess membrane damage to the spirochetes and round body forms present in
disinfectant-treated samples. SG I is a common dye used to stain purified nucleic acids in various
molecular biology techniques. The SG I/PI assay has been used for viability assessment of B.
burgdorferi after antibiotic exposure, and on other bacteria [73-74]. Like the SYTO 9/PI
(BacLight) assay, Sybr Green I (SG I) is a membrane permeable fluorescent dye that will stain
all cells, whereas Propidium Iodide (PI) is a red membrane impermeable fluorescent dye that will
only stain dead cells or those with significant membrane damage. Thus, live cells fluoresce green
and dead cells fluoresce red due to PI permeability. Previous studies with B. burgdorferi
determined the optimal cell staining conditions and dye concentrations used in this study [74].
Percent live spirochetes were calculated based on direct cell counts using fluorescence
microscopy, where numbers of live (green) and dead (red) cells were counted in 5 fields at 400X
magnification. Live spirochete populations in treated samples showed >95% for HBSS, ~60%
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for dd H2O, <5% for ACS 200, ~1% for GTA, ~1% for ETH, and <1% for HC (Figure 3A). Live
round body cells in the population were also assessed. Greater than 99% of HBSS treated round
body forms were live (Figure 4 B). Distilled deionized H2O showed <25% live round body types
present in the population, while ACS 200, 1% GTA, and 70% ETH showed <1% live round body
forms. 1% HC showed no live cell forms. Round body induction, as assessed by both darkfield
and fluorescent microscopy cell counts, showed comparable readings (Figure 4 A) for ACS 200
and dd H2O, resulting in ~13-fold increase of round body forms compared to the HBSS control.
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FIGURE 3: B. burgdorferi Spirochete Live/Dead Viability Counts. (A) B. burgdorferi live spirochete percentage
estimated by live/dead staining with SG I and PI after a 30 second contact time. (B) Representative image of SG I/PI
staining of untreated B. burgdorferi (Darkfield, 1000X magnification). Statistical analysis run with One-Way
ANOVA with Dunnett’s multiple comparison test; **** where p<0.0001 using Graph Prism software.
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FIGURE 4: B. burgdorferi Round Body Live/Dead Viability Counts. (A) Percent B. burgdorferi round body form
induction following a 30 sec treatment as estimated by live/dead staining with SG I and PI. (B) Percent of live
Round Body forms following a 30 sec treatment as detected by fluorescent live/dead staining. (C) Representative
image of live/dead staining of B. burgdorferi Round Body forms post 30 second treatment with dd H2O (Fluorescent
microscopy, 1000X magnification).

Similarly, 1% GTA and 70% ETH showed similar results as the HBSS control group, in
round body form induction on contact. HC resulted in complete destruction of cells, as
previously seen. We determined that, as shown in previous studies [1] [4-6], the round body form
can be induced through hypotonic stress. Distilled deionized H2O and ACS 200 showed
immediate induction of round body forms on contact, with a >10-fold increase of round body
forms over the control. Similarly, ACS 200, which is colloidal silver in dd H2O, also resulted in
>10-fold increase in round body form induction from the control. In contrast, ACS 200 showed
no viable (green) round body forms, whereas water did. Although 1% GTA and 70% ETH were
also prepared with dd H2O, these preparations did not significantly increase round body
formation compared with the HBSS control. In addition, 1% HC resulted in almost immediate
lysis of planktonic cells. It was interesting to note the fragility of B. burgdorferi spirochetes and
round body forms to various disinfectants, even with a short contact time of 30-seconds.
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4.4 SYBR GREEN I/PI Planktonic 96-Well Plate Assay
Direct microscopic fluorescent cell counting can be time consuming and inaccurate. For
these reasons, we explored a fluorescent plate reader assay as a rapid means of evaluating
samples. First, we confirmed that the use of the fluorescent dyes SG I and PI could be used in
generating a linear model for counting cells in a 96-well plate. Live B. burgdorferi cells were
diluted from 104-108 cells/well. The resulting linear fit revealed an R2 value of 0.997 between
total fluorescent signal and the number of live Borrelia burgdorferi cells in solution (Figure 5A).
Separated R2 values for each log section revealed that the limit of resolution for cell detection
was near 5 X 105 cells, which correlates with previous studies [73].
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FIGURE 5: Linear Relationship between Total fluorescent signal of live B. burgdorferi and the Total Available
Number of Cells in Solution. (A) Linear relationship of total fluorescent signal of 105-108 B. burgdorferi cells in test
wells. (B) Separated from 5A, 107-108 B. burgdorferi cells. (C) Separated from 5A, 106-107 B. burgdorferi cells.
(D) Separated from 5A, 105-106 B. burgdorferi cells. (E) Separated from 5A, 104-105 B. burgdorferi cells.

From the linear representation of the data between 5 X 106 to 1 X 108 cells we
determined that a final working concentration of near 107 cells per well would be ideal for
further experiments. For our purposes, we became interested in using the ratio of live to dead
cells in solution using the SG I (live) and PI (dead) viability dyes. Although a SG I/PI assay has
been used for viability assessment for other bacteria and B. burgdorferi in antibiotic
susceptibility [73-74], it has not been used to evaluate B. burgdorferi susceptibility to chemical
antimicrobials. B. burgdorferi culture wells containing 1 X 106, 2 X 106, 5 X 106, 8 X 106, and 1
X 107 cells were made and stained with SG I/PI mixture, and then read at an excitation
wavelength of 485nm and emission wavelengths of 535nm (green) and 635 nm (red). This was
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done to test the linear relationship of serially diluted B. burgdorferi cells to the green/red ratio of
the viability dyes. The linear relationship between green/red fluorescence ratios of B. burgdorferi
cells showed an R2=0.974 (Figure 6A) representing the variation of the green/red ratios as
explained by the number of known B. burgdorferi cells present in the well. This data is
comparable with previously described SG I/PI assays performed for antibiotic susceptibility
testing [73-74]. Having established that the green/red ratios correlate with known total B.
burgdorferi cells, we measured the green/red ratios of known proportions of percent live B.
burgdorferi cells at our working concentration of 107 cells. This would provide a means of
percent live cell estimation from the solution. Heat-killed B. burgdorferi were made in HBSS,
which was heated for 20 minutes at 55oC and cooled to room temperature on ice before
combining with live B. burgdorferi at 5 different proportions, 0, 20, 50, 80, and 100% live cells
prepared by mixy-mix method (Figure 6B). The resulting curve is consistent with similar curves
developed for B. burgdorferi antibiotic susceptibility testing [73-74]. In addition, we tested this
method with a total concentration of 1 X 107 and 2 X 107 B. burgdorferi live cells at 7 different
proportions, 0, 12.5, 25, 50, 75, 87.5, and 100% to assess if there was a major difference in the
green: red ratio linear fit to a doubling of fluorescent signal. A doubling of fluorescent signal
revealed similar green: red ratio results to our original test (Figure 6C). Furthermore,
fluorescence microscopy imaging was consistent with live/dead ratio values (Figure 6D).
Fluorescence imaging produced comparable values with predetermined proportions of live/dead
B. burgdorferi cells.
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FIGURE 6: Linear Relationship between B. burgdorferi Viability and the Green/Red Fluorescence Ratios. (A) The
linear relationship between the green/red fluorescence ratios and number of live B. burgdorferi spirochetes in
solution. (B) The linear relationship between the green/red fluorescence ratios and percent live B. burgdorferi
spirochetes at concentrations 10 4-107. Percent live (vs heat-killed) spirochetes used were: 100, 80, 50, 20, and 0.
The line is a least-squares fit of the relationship between percentage of live bacteria and the green/red fluorescence
ratio. (C) The linear relationship between the green/red fluorescence ratios and percent live B. burgdorferi
spirochetes at a concentration of 1 X 107 and 2 X 107 using live proportions of 100, 87.5, 75, 50, 25, 12, and 0. (D)
Representative fluorescence microscopy images showing live/dead staining of known proportions (0, 25, 50, 75,
100%) of live B. burgdorferi spirochetes (i-v, respectively). 100, 87.5, 75, 50, 25, 12, and 0
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Having confirmed that the SG I/PI assay could be effectively utilized in the rapid
assessment of viable B. burgdorferi, we then proceeded to apply the assay to disinfectant-treated
samples. HBSS treatment showed >99% of cells were alive (Figure 7). Distilled deionized H2O
treatment showed that ~10% of cells present were living, while ACS 200, 1% GTA, 70% ETH
and 1% HC treatments resulted in <4% cells surviving. Ratios of green/red were comparable to
previously published live/dead ratios obtained when the background interference of the carrier
medium was taken into account [73-74].

FIGURE 7: The Effects of Different Antimicrobials on the Viability of B. Burgdorferi. Percent live B. burgdorferi
after 30 (A) and 60 (B) second contact times with various disinfectants as measured by green/red ratios using SG
I/PI staining. Statistical analysis run with One-Way ANOVA with Dunnett’s multiple comparison test; **** where
p< 0.0001 using Graph Prism software.

We determined that the Lower Limit of Quantitation (LLOQ), where various proportions
of live B. burgdorferi were tested in 18 wells each, was ~4%. Results were similar to direct
counts, with regards to all tested chemical antimicrobials. The variation of 3-4% was similar to
that for the limit of quantification of 105 cells established in the literature with green/red ratios
using SG I/PI [74]. As some of these solutions are potent disinfectants which may cause lysis or
extreme fragility of treated cells, which can then be lysed upon pipetting, it is reasonable to
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assume that as cells in the wells fell below 105 cells per well, there would be errors in the
green/red ratios determined by the assay. To confirm complete kill by HC treatment, samples
were inoculated into fresh BSK-H medium in 24-well plates and incubated for 3 weeks. At
various time points, samples were assessed for motile spirochetes with darkfield microscopy up
to 3 weeks (Table 3). Both HC solutions and ACS 200 treatments showed no recovery of motile
spirochetes after 3 weeks. Exposure to dd H2O, however, showed recovery of viable motile
spirochetes within 1 week. This is consistent with round body reversion from dd H2O and spinal
fluid noted in the literature [1, 6], and the doubling time of viable spirochetes. All neutralizerdisinfectant controls showed motile spirochetes similar to the HBSS controls.
Having shown that the SG I/PI assay was an effective tool in measuring disinfectant
efficacy using B. burgdorferi, we next evaluated the effectiveness of ACS 200 in a silver-binding
environment. ACS 200 was diluted 1/2, 1/4, and 1/8 in dd H2O and HBSS. B. burgdorferi
suspensions were exposed to these dilutions for 30 seconds, followed by neutralization and assay
for green/red ratios using SG I/PI viability staining in 96-well plates. When diluted in dd H2O,
ACS 200 maintained a consistent kill of >95% through all dilutions (Figure 8A). As previously
shown, even small quantities of silver ion in dd H2O have potent antimicrobial activity [91].
However, when diluted in HBSS, ACS 200 was significantly less effective at killing B.
burgdorferi. After exposure to ACS 200 diluted 1:2 in HBSS, about 60% of the cells were still
viable; with ACS 200 diluted 1:4, ~70% of the cells were viable, and with 1:8, ~80% of the cells
were viable. Fluorescent microcopy results were comparable to those from the plate reader, for
all ACS dilutions (Figure 8B i-viii).
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FIGURE 8: The Antimicrobial Effects of ACS 200 Diluted in dd H2O and HBSS on B. burgdorferi. (A) Percent live
B. burgdorferi after a 30 second contact as measured by green/red ratios following SG I/PI staining. (B)
Fluorescence microscopy images of ACS 200 dilutions in dd H2O and HBSS; HBSS (i), ACS 200 (ii), 1:2,4,8 dd H2O
dilutions (iii-v respectively), 1:2,4,8 HBSS dilutions (vi-viii respectively). Statistical analysis run with One-Way
ANOVA with Dunnett’s multiple comparison test; **** where p<0.0001 using Graph Prism software.

4.5 Crystal Violet Biofilm Assay
The crystal violet biofilm assay was used to quantify the amount of biofilm remaining
following a 30-minute treatment with various disinfectants. Though typically used to assess
firmly attached biofilms, the crystal violet assay can also be applied to suspended biofilm-like
colonies [9]. First, we confirmed a linear relationship between crystal violet absorbance and
concentration, using both 1:10 and 1:2 dilutions (Figure 9A and 9B). The least-squares fit line
showed a R2=1 for 10-fold serial dilutions of 0.01% crystal violet and a R2=0.999 for 2-fold
serial dilutions of the same solution. B. burgdorferi biofilms were generated through static
culture in 24-well plates for 10 days, followed by treatment with various antimicrobials.
Treatments were compared to the HBSS control to obtain percent of control values of the
remaining B. burgdorferi biofilm.
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FIGURE 9: Quantitative Evaluation of Biofilm-Like Colonies of B. burgdorferi Following Disinfectant Treatment.
(A) Linear relationship between absorbance at 590 nm and crystal violet concentration (serial 1:10 dilutions of
0.01%). (B) Linear relationship between absorbance at 590 nm and crystal violet concentration (1:2 dilutions of
0.01%). (C) Reduction of B. burgdorferi biofilms following a 30-minute contact with various disinfectants, as
determined by crystal violet staining. (D) Extracted crystal violet stain from biofilm treated wells. Statistical
analysis run with One-Way ANOVA with Dunnett’s multiple comparison test; **** where p<0.0001 and * where
p<0.05 using Graph Prism software.

The remaining biofilm after each treatment was as follows (Figure 9C); ACS 200, ~45%,
1% HC, ~15%, 5% HC, ~1%, 1% GTA, ~ 20%, 70% ETH, ~ 20%, and dd H2O, ~95%. As
expected, HC was best at biofilm degradation. However, both concentrations of HC resulted in
no viable cells of any kind when examined microscopically, yet a small amount of crystal violet
signal remained. We concluded that a small amount of biofilm matrix and cellular debris were
detected by the crystal violet assay.
4.6 SYBR GREEN I/PI Biofilm Viability Assay
To qualitatively assess the effects of different disinfectants on B. burgdorferi biofilms in
wells, disinfectants were applied for 30 minutes, wells were neutralized and then stained with SG
I/PI. The percent estimates of green (live) cells in the biofilm were determined by visual
39

estimation of green present in the biofilm. HBSS controls showed >98% of cells in the biofilm to
be live, while these same values for the other treatments were: ACS 200, ~2; 1% HC, <1%; 5%
HC, <1%; 1% GTA, ~10%; 70% ETH, ~ 2%; and dd H2O, ~40% (Figure 10). Both ACS 200 and
dd H2O induced heavy increases in round body forms within the biofilm. We believe this is due
to the low osmotic strength of these solutions. ACS 200-treated biofilms, unlike the dd H2O,
however, showed nearly all-round body and spirochete forms to be nonviable (red). Fluorescence
microscopy analysis using viability stains of biofilms, in tandem with quantification of biofilms
using the crystal violet assay, revealed the nature of antimicrobial-treated biofilms. The crystal
violet assay showed that following dd H2O treatment, ~95% of the biofilm remained. However,
when viewed with fluorescent microscopy, it became clear that most of the organisms in the dd
H2O -treated biofilm had undergone a shift to primarily round body forms, and that about ~40%
of the biofilm stained viable (green). The two HC solutions showed nearly identical results with
remaining biofilm debris fragments, if any, staining red. GTA and ETH treatments showed that
only a small fraction of the biofilms were viable. It was notable that 70% ETH occasionally
produced excessive clumping of treated biofilm formations. Biofilm viability estimations by SG
I/PI staining are shown in Table 1. The spirochetes and round body forms of B. burgdorferi
appeared to be particularly susceptible to most of the antimicrobials tested here. However, the
biofilm-like colonies showed surprising resilience to a 30-minute contact with these
disinfectants.
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FIGURE 10: Qualitative Assessment of Viable B. burgdorferi Biofilm-Like Colonies. Representative fluorescence
microscopy images of 30-minute disinfectant-treated biofilm-like colonies stained with SG I/PI. (A) HBSS, (B) 1%
GTA, (C) 5% HC, (D) dd H2O, (E) ACS 200, (F), 70% ETH, and (G) 1% HC. Numbers following letters indicate
replicate number (20X Magnification).

TABLE 1: Qualitative Assessment of Viable B. Burgdorferi in Biofilms Stained with SG I/PI.

HBSS
1% GTA
5% HC
dd H2O
ACS 200
70% ETH
1% HC

R1

100%
10%
0%
40%
1%
0%
0%

R2

100%
10%
0%
40%
2%
1%
0%

R3

98%
5%
0%
35%
1%
2%
0%

Assessment summary table of Figure 10 images with estimations in percent of live (green) staining by SG I within
the tested biofilms. Five fields were viewed for each tested well, and all tests were done in triplicate.
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FIGURE 11: Qualitative Assessment Summary of Viable B. burgdorferi Biofilm-Like Colonies. Representative
fluorescence assessment summary of Figure 10 images with estimations in percent of live (green) staining by SG I
within the tested biofilms. Biofilm-like colonies were treated with disinfectant solutions for 30 minutes then stained
with SG I/PI. Five fields were viewed for each tested well, all tests were done in triplicate. Statistical analysis was
run with One-Way ANOVA with Dunnett’s multiple comparison test; **** where p<0.0001 using Graph Prism
software.

4.7 Complete-Kill Assay
Due to the limits of testing the entire volume of a test sample with microscopy and the
4% potential error in the 96-well plate assay, we were interested to know if any of the cells in
wells with signals below 4% were alive and could be resuscitated. Samples were run as
previously tested, washed, placed into fresh BSK-H medium, and incubated for 3 weeks.
Assessment for viability was performed with direct visualization of motile spirochetes in solution
using darkfield microscopy after 3 weeks of incubation. Table 2 shows the growth results of the
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spirochete cultures post contact with chemical disinfectants for 30 seconds, 1 minute, and 3
minutes. While HBSS and dd H2O showed growth recovery, GTA and HC solutions remained
sterile. ACS 200 silver solution showed 1 of 3 wells resulting in growth recovery. Biofilm
recovery was also tested using a 30-minute contact time (Table 3). All samples tested resulting in
a recovery of growth except for the HC solutions.
TABLE 2: Three Week Complete Kill Assessment Single Spirochetes

HBSS
1% GTA
5% HC
dd H2O
ACS 200
70% ETH
1% HC

30sec
G, G, G
NG, NG, NG
NG, NG, NG
G, G, G
G, NG, NG
NG, NG, NG
NG, NG, NG

1 minute
G, G, G
NG, NG, NG
NG, NG, NG
G, G, G
NG, NG, NG
NG, NG, NG
NG, NG, NG

3 minutes
G, G, G
NG, NG, NG
NG, NG, NG
G, G, G
NG, NG, NG
NG, NG, NG
NG, NG, NG

Complete kill assessment of single spirochete wells post treatment with antimicrobials at 30seconds, 1 minute, and 3
minutes contact time. Wells were assessed for cell growth with darkfield microscopy through motility observation;
growth (G), no growth (NG) repeated in triplicate. Spirochete motility was assessed at 3 weeks post inoculation.

TABLE 3: Three Week Complete Kill Assessment of B. burgdorferi Biofilms

HBSS
1% GTA
5% HC
dd H2O
ACS 200
70% ETH
1% HC

30 minutes
G, G, G
G, G, G
NG, NG, NG
G, G, G
G, G, G
G, G, G
NG, NG, NG

Complete kill assessment of B. burgforferi biofilm wells post treatment with antimicrobials at a 30-minute contact
time. Wells were assessed for cell growth with darkfield microscopy through motility observation; growth (G), no
growth (NG) repeated in triplicate. Spirochete motility was assessed at 3 weeks post inoculation.
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4.8 Summary
In summary, the goal of these studies was to identify a method for the rapid evaluation of
disinfectants on the various morphological forms of B. burgdorferi. We showed SG I/PI staining
to be a novel and rapid method for disinfection assessment on the various morphological forms
of B. burgdorferi. In addition, SG I/PI staining provided valuable information as to the
differential susceptibility of the various morphological forms: spirochetes, round body forms,
and biofilm-like colonies. A major finding of this work is that biofilms of B. burgdorferi are
orders of magnitude more resistant to chemical disinfection than the spirochete or round body
forms. Although our study focused specifically on B. burgdorferi, this methodology could be
adapted to assess disinfectant efficacy for other medically relevant, difficult to cultivate
spirochetes. In addition, our study provides evidence that the common published information for
B. burgdorferi spill cleaning methods may need to be revised [37].
FUTURE WORKS
Now that this protocol has been shown useful for assaying disinfectant efficacy for
spirochetes and other morphological forms of B. burgdorferi, the next steps would be further
accuracy enhancements. The current protocol is based on manual visual counts and live: dead
ratio determinations using a fluorescence plate reader. A more ideal method would be a multistaining technique processed with flow cytometry that would discriminate between
morphological states and live/dead viability. In addition, more research exploring a broader
range of disinfectants and antimicrobials on B. burgdorferi is needed. Although this method is
relatively rapid and can be completed within two days (and is much quicker than waiting for
organisms to grow 3 weeks post contact), it is demanding, and would benefit from further
optimization of work flow and simplification where possible. Currently the protocol requires,
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from start to finish, 18 hours of continuous work. All solutions were immediately before each
test to ensure optimal antimicrobial activity. Currently, the protocol also demands the complete
monopolization of a lab centrifuge to wash cells between contacts. Further optimization of work
flow and simplification of the protocol would be beneficial. For instance, whether fewer wash
cycles would give the same results, or result in less physical damage of the cells is unknown.
Furthermore, if the 96-well protocol could be run with fewer transitions prior to reading, this
may also provide more assurance that damaged cells are the result of the antimicrobial
compounds and not manipulation-induced damage. Each wash cycle consists of 10 minutes in
the centrifuge to spin down cells. With many replicates and test agents, this amounts to a
significant centrifuge wait time. If possible, it would be ideal to reduce the amount of time used
to pellet cells, while still maintaining confidence in complete cell collection. Ideally, the test
would greatly benefit from being able to be run through the 96-well plate assay with the viability
dyes in the neutralizer. This would reduce pipetting time, the physical damage to the cells, and
the total number of wash cycles in which cells might be lost.
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